Testicular cancer treatments may incur risks
Wednesday, 23 June 2010- Testicular cancer survivors treated with chemotherapy and radiotherapy are at increased risk for cardiovascular disease (CVD), researchers reported at the American Society of Clinical Oncology annual...
Edited by: ES
UK researchers identify three new genetic variants that increase testicular cancer risk
Wednesday, 16 June 2010- A study led by the London-based Institute of Cancer Research (ICR) has identified three new genetic risk factors for testicular cancer. The findings, published online in Nature Genetics, come during the...
Edited by: JV
Long-term marijuana smokers face higher testis cancer risk
Monday, 26 April 2010- Frequent and long-term marijuana use increased the risk of testicular germ-cell cancer as much as threefold, according to findings based on medical records from a large cancer center in the US.
"The...
Edited by: JV
Management of testicular neoplasms in France and compliance with national guidelines
Monday, 29 March 2010- Testicular neoplasms (TN) are uncommon and for curable tumours with standardised treatment, guidelines are available. Treatments, however, may lead to adverse effects (long term severe toxicities, secondary...
Edited by: JV
Testis cancer incidence remains high in Caucasian populations
Thursday, 18 March 2010- Epidemiologic studies on testicular cancer have focused primarily on European countries. Global incidence and mortality have been less thoroughly evaluated.
A. M. Rosen and colleagues of the University...
Edited by: JV
Testicular cancer diagnosis by non-invasive MRI
Friday, 26 February 2010- Researchers have found that non-invasive magnetic resonance imaging (MRI) is a good diagnostic tool for the evaluation and staging of testicular cancer and may improve patient care by sparing some men...
Edited by: JV
Study suggests postchemotherapy RLND not necessary after complete remission
Tuesday, 29 December 2009- Patients obtaining a CR after first-line chemotherapy can be safely observed without PC-RPLND, according to a report published in the early online release of Journal of Clinical Oncology. It concludes...
Edited by: ES
Optimal management of patients with nonseminomatous germ cell tumour
Monday, 28 December 2009- Controversy arises regarding the optimal management of patients with nonseminomatous germ cell tumor (NSGCT) who achieve a serologic and radiographic complete remission (CR) to systemic chemotherapy....
Edited by: JV
Relatives of boys with hypospadias not at risk for testis cancer
Wednesday, 23 December 2009- Boys with the sexual birth defects known as hypospadias and cryptorchidism are at risk for developing testicular germ cell cancer, but their relatives are not, according to a new study published in...
Edited by: JV
Long-term testis cancer survivors experience more neurological side effects
Friday, 27 November 2009- Long-term survivors of testicular cancer who were treated with cisplatin-based chemotherapy experience more severe side effects, including neurological side effects and Raynaud-like phenomena, than men...
Edited by: JV
